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N-methyl-N-nitrosourea (MNU) is widely used to study the mechanism of retinal degenerative diseases
(RDs) because of its selectivity of photoreceptor cell death. Many reports suggest that excessive nitric
oxide (NO) plays a crucial role in neuronal cell death. We hypothesized that nitric oxide synthase (NOS)/
NO are involved in photoreceptor cell death by MNU. We found that the levels of NO increased after MNU
treatment. Furthermore, we demonstrated that neuronal NOS speciﬁc inhibitor attenuated photoreceptor
cell death by MNU in mice. We believe that our ﬁndings might be a new target for the treatment of RDs.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Retinal degenerative diseases (RDs), such as retinitis pigmen-
tosa and age related macular degeneration are major causes of
blindness (1). To clarify the mechanisms and potential treatments
for RDs, there are a number of retinal degeneration animals that
mimic human pathology (2, 3). However, the various pathogenetic
mechanisms of these retinal degenerative diseases have a common
end stage: photoreceptor cell death. One model uses N-methyl-N-
nitrosourea (MNU), an alkylating agent, because of its selective
toxicity to photoreceptor cells through an apoptotic mechanism (4).
Intraperitoneal injection of MNU induces accumulation of intra-
cellular calcium ions in the retina and induces selective photore-
ceptor cell loss (5). Constitutive nitric oxide synthase (cNOS), such
as neuronal NOS (nNOS) and endothelial NOS (eNOS), is activated
by calcium through calmodulin activation. There are a lot of reports
that suggest the relationship between photoreceptor cell loss and
nitric oxide (NO) (6, 7). However, there are no reports that suggest
MNU toxicity results from NOS/NO. In this study, we investigated
the role of NOS/NO in photoreceptor cell loss by MNU in mice.y of Pharmaceutical Sciences,
itamagaki, Suzuka 513-8670,
ama).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).The Animal Care and Use Committee of Kanazawa University
and Suzuka University of Medical Sciences approved all animal care
and handling procedures. Male C57BL/6N mice (Japan SLC, Inc.,
Shizuoka, Japan, 8e9 weeks old) were used throughout this study.
Mice were anesthetized by intraperitoneal injection of sodium
pentobarbital (30e40 mg/kg body weight). MNU (60 mg/kg body
weight) treatment was performed by intraperitoneal injection. For
nNOS inhibition, an nNOS inhibitor, ethyl[4-(triﬂuoromethyl)
phenyl]carbamimidothioate (ETPI) (400 nM/eye, Cayman Chemical,
Ann Arbor, Michigan, USA), was intraocularly injected under
anesthesia immediately after MNU treatment. Apoptotic cells were
detected using In Situ Cell Death Detection Kit, Fluorescein (Roche
Applied Science, Mannheim, Germany) according to the procedure
described by the manufacturer. In brief, the retinal cryosections
were microwaved 0.1 M citrate buffer (pH 6.0), washed, blocked
and incubated with terminal transferase and ﬂuorescein-
conjugated dUTP. To count the number of TUNEL-positive cells in
the outer nuclear layer (ONL), we randomly selected one area
(400  100 mm, covering whole layer) of retina in each image of
section (x 200 magniﬁcation). The number of TUNEL-positive cells
and 40,6-diamidino-2-phenylindole-positive cells in the ONL of the
area was counted using ImageJ software (Wayne Rasband, NIH,
Bethesda, MD, USA). Enucleated eyes were ﬁxed overnight in 4%
paraformaldehyde/phosphate buffer saline (PBS) at 4 C. Afternese Pharmacological Society. This is an open access article under the CC BY-NC-ND
Fig.1. Selective and progressive loss of photoreceptors by MNU. (AeC) MNU-induced
photoreceptor cell death in the ONL revealed by TUNEL staining. (A) 0 day retina, (B)
3 days after vehicle treatment, (C) 3 days after MNU treatment (60 mg/kg). Scale
bar ¼ 20 mm. (D) Graphical representation of percentage of TUNEL-positive cells in the
ONL per visual ﬁeld (200 magniﬁcation). *P < 0.01 vs vehicle control of each day
(n ¼ 8). (EeG) Microscopic images of retinas of 0 day (E), 5 days after vehicle treatment
(F), 5 days after MNU treatment (G). Scale bar ¼ 20 mm. (H) Retinal degeneration was
evaluated by measuring the thickness of ONL of mice retina. Graphical representation
of percentage of ONL thickness against vehicle control for each time point. *P < 0.01 vs
0 day (n ¼ 20). ONL, outer nuclear layer.
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followed by embedding in optimal cutting temperature compound
(Sakura ﬁnetek, Tokyo, Japan). Retinal sections in central areas
(within 300 mm from optic disk) were cut at 12 mm thickness, and
mounted onto silane-coated slides. To evaluate the thickness of
retinal layers, we performed hematoxylin and eosin (HE) staining.
The retinal cryosections were incubated in 0.1 M TriseHCl (pH 8.0)
containing 0.3% Triton X-100 overnight at 23 C. They were then
stained in buffer including NADPH and 4-nitroblue tetrazolium
chloride (Roche Diagnostics Corporation, Indianapolis, IN, USA) for
2e3 h at 37 C. To quantify the density of NADPH diaphorase
(NADPHd) staining in ONL by a blinded observer, we used ImageJ
software (Wayne Rasband). Images were captured by bright ﬁeld
microscopy (under 200magniﬁcation; E600, Nikon). Nitrite levels
were determined using the Griess Reagent system (Promega,
Madison, WI, USA). After homogenization with hypotonic PBS
including 1 mM EGTA and centrifugation (12000 g, 10 min), the
retinal supernatant was mixed with Griess reagent for 10 min. We
thenmeasured the absorbance at 550 nm using amicroplate reader
(Model 680, Bio-Rad Laboratories, Hercules, CA, USA). We used
sodium nitrite to construct a standard curve. For immunohisto-
chemistry, the retinal sections were microwaved in 0.1 M citrate
buffer followed by incubation with primary antibodies, rabbit anti-
nNOS (1:400, Sigma Aldrich, St Louis, MO, USA). The sections were
then incubated with appropriate Alexa Fluor 488 secondary anti-
bodies (1:1000, Molecular Probes, Eugene, OR, USA). We report the
mean ± SEM for 3e5 experiments. Differences between groups
were analyzed using ANOVA followed with Tukey's multi-
comparison test. P-values < 0.05 were considered to be statistically
signiﬁcant.
The number of TUNEL-positive cells in retina after intraperito-
neal injection of vehicle (PBS) did not change within 5 days against
0 day (Fig. 1A, B and D). TUNEL-positive cells were observed only in
the ONL at 3 days after MNU treatment (Fig. 1C) when compared
with the vehicle control of 3 days (Fig. 1B). TUNEL-positive cells in
the ONL dramatically increased and peaked at 3 days after MNU
treatment (Fig. 1D). Vehicle treatment did not affect ONL thickness
within 5 days (Fig. 1F) against 0 day (Fig. 1E). HE staining revealed
that the ONL became progressively and signiﬁcantly thinner in
MNU-treated mice (Fig. 1G, H) when compared with 0 day (Fig. 1E).
Intraperitoneal injection of vehicle did not change the amount of
nitrite productionwithin 5 days compared to 0 day retina (data not
shown). The levels of nitrite in the retina signiﬁcantly increased and
peaked at 3 days after treatment of MNU (Fig. 2A). Because the
activity of NOS is associated with that of NADPHd (8), wemeasured
the changes in NADPHd activity within 3 days (the peak day of
nitrite production) using histochemical staining after MNU treat-
ment. Vehicle treatment did not affect NADPHd activity within 3
days against 0 day (data not shown). We observed intense staining
of NADPHd in inner segment (IS) of photoreceptor cells at 3 days
after MNU treatment (Fig. 2C) compared with 0 day (Fig. 2B).
Therefore, the NOS activity was increased signiﬁcantly in IS at 3
days after MNU treatment (Fig. 2B, C, E). We investigated the
localization of nNOS at 3 days of MNU treatment. Immunostaining
of nNOS (Fig. 2D) was also localized in IS. As the maximum levels of
cell death by MNU were seen at 3 days in TUNEL assay, we evalu-
ated the effect of nNOS activation on MNU-induced photoreceptor
cell death at 3 days. Numerous TUNEL-positive cells were observed
in the ONL at 3 days after MNU treatment (Fig. 3B and D) when
compared with the vehicle control (3 days, Fig. 3A). Treatment of
ETPI, an nNOS inhibitor, clearly inhibited the MNU-induced cell
death in the ONL (Fig. 3C and D). Because the maximum thinning
effect of MNU was observed at 5 days, we evaluated the effect of
ETPI on the MNU-induced change in ONL thickness at 5 days after
MNU treatment. The ONL was signiﬁcantly thinner in MNU-treatedretinas (Fig. 3F and H) when compared with vehicle control (5 days,
Fig. 3E). ETPI signiﬁcantly reduced this MNU-induced thinning of
the ONL (Fig. 3G, H). Quantitative evaluation of ONL thickness
showed that ETPI signiﬁcantly suppressed the MNU-induced
photoreceptor cell loss.
This study has three salient ﬁndings: NO was produced by MNU
treatment; NADPHd-positive staining and nNOS immunoreactivity
were observed in the IS after MNU treatment; nNOS-speciﬁc in-
hibitor suppressed photoreceptor cell death caused by MNU. There
has been an increasing need to establish an animal experimental
model for human retinal degenerative disorders. Herrold originally
reported that MNU causes loss of photoreceptor in golden hamsters
within one week (9). In previous studies, injection of 60 mg/kg
MNU into rats or mice evoked photoreceptor cell loss and depletion
within 7 days of treatment (10). There are several reports on the
mechanism of photoreceptor cell loss caused by MNU (11): a
decrease in antiapoptotic Bcl-2 protein, an increase in proapoptotic
Bax protein, and activation of caspases. Futhermore, Oka et al (5),
reported that total calcium ion in MNU-treated retinas is signiﬁ-
cantly increased, and calcium-dependent protein such as calpain
activity is increased from 1 day after MNU treatment. Although NO
is one of the risk factor for RDs (6), there are no reports which
described the relation between NO and MNU-induced photore-
ceptor cell death. The cNOS activity is strongly induced by elevated
calcium ion in photoreceptor (12). However, eNOS immunoreac-
tivity was detected in retinal vessels, but not in neurons (13). Thus,
we focused on nNOS because of its calcium-dependent activation
and localization (14). In this study, we showed evidence that the
NOS were activated in the IS after MNU intraperitoneal injection,
and nNOS immunoreactivity was observed in the same area.
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Fig. 2. Nitrite production and NADPHd staining in MNU-treated retina. (A) Nitrite production was measured in the retina at various time points after MNU treatment. The con-
centration of nitrite increased within 3 days after MNU treatment. *P < 0.05 vs 0 days, **P < 0.01 vs 0 days (n ¼ 4). (B, C) NADPHd staining in the retina increased in the IS at 3 days
after MNU treatment (C) compared with vehicle control of 3 days (B). Scale bar ¼ 20 mm. IS, inner segment. (D) Immunohistochemistry for nNOS in mouse retina at 3 days after MNU
treatment. (E) Graphical representation of percentage of NADPHd staining intensity against vehicle control for each time point. **P < 0.01 vs 0 days.
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Fig. 3. nNOS-dependent photoreceptor cell death by MNU. (AeD) ETPI inhibited
photoreceptor cell death caused by MNU. TUNEL staining of vehicle control of 3 days
(A), MNU (3 days, B), MNU þ ETPI (3 days, C). Scale bar ¼ 20 mm. (D) Graphical rep-
resentation of percentage of TUNEL-positive cells in ONL per visual ﬁeld (200
magniﬁcation). *P < 0.01 vs vehicle control of 3 days. þP < 0.01 vs MNU (n ¼ 20). (EeG)
Microscopic images of retina treated with vehicle control of 5 days (E), MNU (5 days, F),
MNU þ ETPI (5 days, G). Scale bar ¼ 20 mm. (H) Vertical thickness of ONL in mice retina
at 5 days after MNU treatment. *P < 0.01 vs vehicle control of 5 days, þP < 0.01 vs MNU
(n ¼ 20).
Y. Koriyama et al. / Journal of Pharmacological Sciences 127 (2015) 394e396396Neufeld et al (14) reported that nNOS is abundantly present in the
IS. Oka et al. reported that total calcium ion in MNU-treated retinas
is signiﬁcantly increased before induction of photoreceptor cell
death (5). Koch et al. further reported that NOS activity is strongly
enhanced by elevated free calcium ion in photoreceptor cells (15).
In this study, we clearly showed that ETPI, a selective inhibitor of
nNOS, signiﬁcantly decreased the number of apoptotic cells in the
ONL. These data indicated that nNOS is one of the key molecule forpathogenesis in MNU-induced photoreceptor cell loss. These ﬁnd-
ings in turnwill propose the possibility that nNOS inhibitors and/or
NO scavenger can be one of the new candidates of the therapy for
RDs.
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